These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8810758)

  • 1. [KL-6 in patients with interstitial pneumonitis].
    Hamada H; Sakatani M; Ueda E
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jul; 34(7):771-7. PubMed ID: 8810758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease.
    Kohno N; Awaya Y; Oyama T; Yamakido M; Akiyama M; Inoue Y; Yokoyama A; Hamada H; Fujioka S; Hiwada K
    Am Rev Respir Dis; 1993 Sep; 148(3):637-42. PubMed ID: 8368634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of the the ED046 kit to analyze serum KL-6 in patients with pneumonitis].
    Kitamura S; Hiwada K; Kobayashi J; Kohno N; Kawai T; Satou A; Kasukawa R; Kawakami Y; Andou M; Nakada G; Inoue H; Itou K; Matsushima T; Ogura T; Arakawa M; Yamakido M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jun; 34(6):639-45. PubMed ID: 8741528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis.
    Kohno N
    J Med Invest; 1999 Aug; 46(3-4):151-8. PubMed ID: 10687309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical usefulness of KL-6 as a serum marker of idiopathic interstitial pneumonia].
    Kohno N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():186-9. PubMed ID: 9216213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].
    Ogawa N; Shimoyama K; Kawabata H; Masaki Y; Wano Y; Sugai S
    Ryumachi; 2003 Feb; 43(1):19-28. PubMed ID: 12692986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of CD30 as a marker for th2 lymphocytes in bronchoalveolar lavage in interstitial lung diseases.
    Petkova D; Xaubet A; Picado C; Filella X; Agusti C; Luburich P; Rodriguez-Roisin R
    Respir Med; 2000 Apr; 94(4):345-9. PubMed ID: 10845432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical importance of bronchoalveolar lavage fluid and blood cytokines, surfactant protein D, and Kerbs von Lungren 6 antigen in idiopathic pulmonary alveolar proteinosis.
    Lin FC; Chen YC; Chang SC
    Mayo Clin Proc; 2008 Dec; 83(12):1344-9. PubMed ID: 19046553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypersensitivity pneumonitis monitored with serum KL-6, a marker of interstitial pneumonia].
    Kobayashi J; Tsukagoshi M; Hagiwara S; Kitamura S; Hirota N; Saito K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jul; 34(7):837-42. PubMed ID: 8810769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The expression and clinical role of KL-6 in serum and BALF of patients with different diffuse interstitial lung diseases].
    Zhu C; Zhao YB; Kong LF; Li ZH; Kang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Feb; 39(2):93-7. PubMed ID: 26879611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical study on KL-6 and SP-D in sera of patients with various pulmonary diseases].
    Sugimoto H; Okada E; Hashimoto N; Suzuki S; Yoshida H; Totani Y; Ameshima S; Ishizaki T; Miyamori I
    Rinsho Byori; 2000 Jun; 48(6):554-60. PubMed ID: 10897675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of alveolar macrophages in the pathogenesis of idiopathic interstitial pneumonia].
    Suga M; Iyonaga K; Ando M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():175-80. PubMed ID: 9216211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine deaminase activity and lysozyme levels in bronchoalveolar lavage fluid in patients with pulmonary tuberculosis.
    Orphanidou D; Stratakos G; Rasidakis A; Toumbis M; Samara J; Bakakos P; Jordanoglou J
    Int J Tuberc Lung Dis; 1998 Feb; 2(2):147-52. PubMed ID: 9562125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases.
    Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Skibova J; Striz I
    Scand J Immunol; 2009 Mar; 69(3):268-74. PubMed ID: 19281539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Extracellular components of bronchoalveolar lavage fluid (BALF) as a marker of the activity of interstitial pulmonary diseases. III: Phospholipids to protein concentration ratio].
    Zielonka TM; Wałajtys-Rode E; Jasińska R; Chazan R; Droszcz W
    Przegl Lek; 1999; 56(2):144-7. PubMed ID: 10375948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of serum markers KL-6 and SP-D for interstitial pneumonia associated with connective tissue diseases].
    Suematsu E; Miyamura T; Shimada H; Nakao R; Yamamoto M
    Ryumachi; 2003 Feb; 43(1):11-8. PubMed ID: 12692985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis.
    Takahashi T; Munakata M; Suzuki I; Kawakami Y
    Am J Respir Crit Care Med; 1998 Oct; 158(4):1294-8. PubMed ID: 9769294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An evaluation of fibronectin and IgG in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
    Zhao HW; Lu CJ; Li ZH
    Zhonghua Jie He He Hu Xi Za Zhi; 1994 Apr; 17(2):93-5, 127. PubMed ID: 7994776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Extracellular components of broncho-alveolar lavage fluid (BALF) as markers of interstitial pulmonary disease activity. II. Phospholipid concentration].
    Zielonka TM; Wałajtys-Rode E; Jasińska R; Chazan R; Droszcz W
    Przegl Lek; 1998; 55(12):654-8. PubMed ID: 10354716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced sputum in patients with interstitial lung disease: a non-invasive surrogate for certain parameters in bronchoalveolar lavage fluid.
    Sobiecka M; Kus J; Demkow U; Filewska M; Jozwik A; Radwan-Rohrenschef P; Chorostowska-Wynimko J
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():645-57. PubMed ID: 19218691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.